PC-0120 · Supporting organization or system

Food and Drug Administration approval system

Drug-approval system interacting with patents and experimental-use rules.

regulatory infrastructureDocumented in the book

About this project

Directory status
Supporting record
How the book uses it
Supporting work
Status in the book
operating at book date
Book citation
Ch. 8, pp. 214, 239-242
Last checked
Current status not yet reviewed

Current status

Current status has not yet been reviewed. The book description and citation remain available below.

Suggest an update

What this record includes

Type of project

regulatory infrastructure

Work described in the book

Drug-approval system interacting with patents and experimental-use rules.

Responsible organization

The responsible organization, funding, and governance still need review.

Long-term access

Present-day preservation information has not yet been reviewed. Historical links remain below.

Book source

This section summarizes what the book says and gives its chapter and printed pages. Present-day updates appear separately above.

Chapter 8 · How to Build a Commons: Is Intellectual Property Constrictive, Facilitating, or Irrelevant?

Drug-approval system interacting with patents and experimental-use rules.

Printed pages 214, 239-242 · Supporting work · regulatory infrastructure · described in the main text

Sources and links

Related records

These records share the book type regulatory infrastructure. This connection supports browsing. It does not show that the projects worked together.

No related records are listed yet.